资讯
3 天
MedPage Today on MSNPulmonary Rehabilitation for COPD Pushes ForwardHome-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but ...
Canadian wildfire smoke has entered the Upper Midwest and poses significant health impacts in the hardest-hit areas.
13 天
Amazon S3 on MSNWhat is Chronic Obstructive Pulmonary DiseaseMD, CFPC, FCFP, Family Physician, discusses What is Chronic Obstructive Pulmonary Disease.
3 天
MedPage Today on MSNEasing Airway Assaults in COPDFor COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...
Last fall, the hospital’s pharmacy team launched an effort aimed at cutting readmission rates for COPD, which are notoriously ...
6 天
Clinical Trials Arena on MSNSanofi and Regeneron report results from two Phase III trials of COPD treatmentSanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.
Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果